406913-72-2
Chemical Structure
BMS-250749
- CAS No.: 406913-72-2
- Formula:C26H18F3N3O6
- Molecular Weight:525.43
IUPAC Name: 3,9-difluoro-12-((2R,3R,4R,5S,6R)-5-fluoro-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-12,13-dihydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione
InChIKey: MUXIBMYSVWHKJF-KLQAUAMZSA-N
SMILES: O=C1NC(C2=C1C3=C(NC4=C3C=C(C=C4)F)C5=C2C6=C(C=CC(F)=C6)N5[C@H]7[C@H](O)[C@@H](O)[C@@H]([C@H](O7)CO)F)=O
Biological Activity: BMS-250749 is a topoisomerase I (Top I) inhibitor of the fluoroglycosyl-3,9-difluoroindolecarbazole class. BMS-250749 exhibits potent cytotoxicity and selectivity, and shows curative antitumor activity against Lewis lung cancer. BMS-250749 exhibits broad-spectrum antitumor activity superior to CPT-11 in certain preclinical xenograft models.[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BMS-250749 | BMS-250749 is a topoisomerase I (Top I) inhibitor of the fluoroglycosyl-3,9-difluoroindolecarbazole class. BMS-250749 exhibits potent cytotoxicity and selectivity, and shows curative antitumor activity against Lewis lung cancer. BMS-250749 exhibits broad-spectrum antitumor activity superior to CPT-11 in certain preclinical xenograft models.. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
